Hambleton Julie

Average Profitability
34.51%
Insider Buys Quantity
2
Insider Buys Sum
$279,100.00
Insider Sells Quantity
7
Insider Sells Sum
$1.05M

Insider Activity of Hambleton Julie

According to the SEC Form 4 filings, Hambleton Julie, being in a position of

  1. director at IGM Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 15132 shares for $211,848,
    over all time since 2019-09-18, has bought 10000 shares for $183,100, and sold 21132 shares for $691,848.

The largest purchase of all time was on 2019-09-18 and amounted to 10000 shares of IGM Biosciences, Inc. for $183,100.

The largest sale of all time was on 2021-06-01 and amounted to 4000 shares of IGM Biosciences, Inc. for $320,000.

Biography of Hambleton Julie

No biography is available at this moment.

2024-07-25SaleIGM Biosciences, Inc.
IGMS
director
15,132
0.0297%
$14.00$211,848-11.82%
2024-06-03SaleSpringWorks Therapeutics, Inc.
SWTX
director
4,648
0.006%
$40.03$186,048-6.37%
2023-07-19SaleSpringWorks Therapeutics, Inc.
SWTX
director
2,418
0.0023%
$29.31$70,876+28.19%
2023-06-20SaleSpringWorks Therapeutics, Inc.
SWTX
director
2,400
0.0021%
$26.92$64,603+25.62%
2023-03-15SaleSpringWorks Therapeutics, Inc.
SWTX
director
1,106
0.0011%
$31.50$34,841-12.45%
2021-08-09SaleIGM Biosciences, Inc.
IGMS
director
2,000
0.0058%
$80.00$160,000-75.08%
2021-07-20PurchaseErasca, Inc.
ERAS
director
6,000
0.005%
$16.00$96,000-35.39%
2021-06-01SaleIGM Biosciences, Inc.
IGMS
director
4,000
0.012%
$80.00$320,000-37.72%
2019-09-18PurchaseIGM Biosciences, Inc.
IGMS
director
10,000
0.1785%
$18.31$183,100+104.4%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.